Oncology/Hematology market research reports by DelveInsight

• T cell Lymphoma -Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  T cell Lymphoma -Pipeline Insight, 2023 DelveInsight’s, “T-cell Lymphoma -Pipeline Insight, 2023” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More

• Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 2,000

  Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023 DelveInsight’s, “Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the pipeline d ... Read More

• Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032

  Jun 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032 Key Highlights: In Japan, the contribution of KRAS mutations is lower compared to Western countries like the United States and Europe In the United States, KRASG12C is present in ~ ... Read More

• Triple Negative Breast Cancer - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  Triple Negative Breast Cancer - Pipeline Insight, 2023 DelveInsight’s, “Triple Negative Breast Cancer - Pipeline Insight, 2023,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles ... Read More

• Anal Cancer - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 1,250

  Anal Cancer - Pipeline Insight, 2023 DelveInsight’s, “Anal Cancer - Pipeline Insight, 2023” report provides comprehensive insights about 6+ companies and 8+ pipeline drugs in Anal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It a ... Read More

• Ovarian Cancer- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  Ovarian Cancer- Pipeline Insight, 2023 DelveInsight’s, “Ovarian Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Ovarian Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pro ... Read More

• Metastatic Uveal Melanoma - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Metastatic Uveal Melanoma - Pipeline Insight, 2023 DelveInsight’s, “Metastatic Uveal Melanoma - Pipeline Insight, 2023,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Metastatic Uveal Melanoma pipeline landscape. It covers the pipeline drug profiles, including ... Read More

• Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023 DelveInsight’s, “Angioimmunoblastic T cell Lymphoma – Pipeline Insight, 2023,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Angioimmunoblastic T cell Lymphoma pipeline landscape. It covers the pipelin ... Read More

• HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 2,500

  HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023 DelveInsight’s, “HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2 Negative Breast Cancer pipeline landscape. It cov ... Read More

• Blood Cancer Diagnostics Market Insights, Competitive Landscape and, Market Forecast - 2027

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Blood Cancer Diagnostics Market Insights, Competitive Landscape and, Market Forecast - 2027 BLOOD CANCER DIAGNOSTICS MARKET BY TYPE (PRODUCTS [INSTRUMENTS, ASSAY KITS AND REAGENTS] AND SERVICES) TEST TYPE (BLOOD TESTS, IMAGING TESTS, BIOPSY, AND MOLECULAR TESTS), BY END-USER (HOSPTIALS, CLINICS, AND ... Read More

• Mesothelioma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Mesothelioma - Pipeline Insight, 2022 DelveInsight’s, “Mesothelioma - Pipeline Insight, 2022,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Mesothelioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Peritoneal Cancer - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Peritoneal Cancer - Pipeline Insight, 2022 DelveInsight’s, “Peritoneal cancer – Pipeline Insight, 2022,” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Peritoneal cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

• HER2 Positive Gastric Cancer - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  HER2 Positive Gastric Cancer - Pipeline Insight, 2022 DelveInsight’s, “HER2 Positive Gastric Cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in HER2 Positive Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, i ... Read More

• Marginal Zone Lymphoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Marginal Zone Lymphoma - Pipeline Insight, 2022 DelveInsight’s, “Marginal Zone Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Marginal Zone Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical ... Read More

• Adenoid Cystic Carcinoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Adenoid Cystic Carcinoma - Pipeline Insight, 2022 DelveInsight’s, “Adenoid Cystic Carcinoma- Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It covers the pipeline drug profiles, including clinica ... Read More

• Testicular Cancer - Pipeline Insights, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Testicular Cancer - Pipeline Insights, 2022 DelveInsight’s, “Testicular Cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Testicular Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

• Head and Neck cancer - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 3,000

  Head and Neck cancer - Pipeline Insight, 2022 DelveInsight’s, “Head and Neck cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in Head and Neck cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More

• Cancer Immunotherapy Market Insights, Competitive Landscape and, Market Forecast - 2027

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Cancer Immunotherapy Market Insights, Competitive Landscape and, Market Forecast - 2027 CANCER IMMUNOTHERAPY MARKET BY TYPE (MONOCLONAL ANTIBODIES, IMMUNOMODULATORS, CANCER VACCINES, CHECKPOINT INHIBITORS, AND OTHERS), BY INDICATION (LUNG CANCER, BREAST CANCER, PROSTATE CANCER, COLORECTAL CANCER, AN ... Read More

• Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2022 DelveInsight’s, Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Primary Mediastinal Large B-Cell Lymphoma pipeline landscape. I ... Read More

• Lung Adenocarcinoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Lung Adenocarcinoma - Pipeline Insight, 2022 DelveInsight’s, “Lung Adenocarcinoma - Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Lung Adenocarcinoma pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Head and Neck cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Head and Neck cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Head and Neck Cancer (HNC) - Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of the Head and neck cancer (HNC) historical and forecasted epidemiolog ... Read More

• Intratumoral Cancer Therapies - Market Insight, Epidemiology And Market Forecast - 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 9,500

  Intratumoral Cancer Therapies - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight's "" Intratumoral cancer therapies- Market Insight, Epidemiology and Market Forecast-2032"" report delivers an in-depth understanding of the Intratumoral cancer therapies, historical and forecasted e ... Read More

• Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast – 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast – 2032 DelveInsight's "" Oncolytic Virus Therapies (OVTs)- Market Insight, Epidemiology and Market Forecast Forecast-2032"" report delivers an in-depth understanding of the Oncolytic Virus Therapies (OVTs), historical ... Read More

• Hematological Cancer (Blood Cancer) Therapeutics- Market Insights, Competitive Landscape and, Market Forecast - 2027

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Hematological Cancer (Blood Cancer) Therapeutics- Market Insights, Competitive Landscape and, Market Forecast - 2027 Hematological Cancer (Blood Cancer) Therapeutics By Indication (Leukemia, Lymphoma, And Myeloma), By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, And Other Therapies), By E ... Read More

• Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 9,500

  Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Pancreatic Cancer - Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of the pancreatic cancer historical and forecasted epidemiology as well as the pancreatic ... Read More

< prev 4 5 6 7 8 9 10 11 12 13 next >